Bio-Thera Solutions, Ltd.
Bio-Thera Solutions is a China-based biopharmaceutical company developing innovative biologic therapies alongside biosimilar medicines. Its scientific work includes antibody therapeutics and other protein-based treatment approaches for serious diseases. The company emphasizes oncology, autoimmune diseases, cardiovascular conditions and selected additional therapeutic areas. Bio-Thera operates from Guangzhou, China, and its shares trade on the Shanghai Stock Exchange STAR Market under code 688177. Its inclusion reflects proprietary therapeutic research and development, not merely biosimilar distribution or contract manufacturing.
Company at a glance
Corporate information
- Company entity
- Bio-Thera Solutions, Ltd.
- Headquarters / principal office
- China
- Founded
- Not verified
- Ownership / capital status
- Publicly tradedPublicly listed
- Official corporate reference
- https://www.bio-thera.com/
- LinkedIn company page
- Independent company page not verified
Profile review: 2026-11-08 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Listed issuer and R&D focus
SSE STAR: 688177
antibody therapeutics · biologics · biosimilars
oncology · autoimmune disorders · cardiovascular disease
Last independently verified:
Disease tags match recorded text mentions and require program-level verification.
Technology, programs & evidence
Bio-Thera Solutions is a China-based biopharmaceutical company developing innovative biologic therapies alongside biosimilar medicines. Its scientific work includes antibody therapeutics and other protein-based treatment approaches for serious diseases. The company emphasizes oncology, autoimmune diseases, cardiovascular conditions and selected additional therapeutic areas. Bio-Thera operates from Guangzhou, China, and its shares trade on the Shanghai Stock Exchange STAR Market under code 688177. Its inclusion reflects proprietary therapeutic research and development, not merely biosimilar distribution or contract manufacturing.
Business, technology & evidence
- SecuritiesSSE STAR: 688177
Individual program detail is not recorded. Consult the original sources below.
Related news & literature
Company-name matches are discovery leads; verify entity identity and transaction roles in the original source.
Showing 0 / 0 related items
No cataloged update explicitly mentions this company.
Same-field reading (not company-specific)
Research this company together
Discussions are for signed-in members. Personal notes remain separate from company research.
Sign in to joinSources & open questions
- Official issuer and R&D disclosure · Bio-Thera Solutions, Ltd. ↗Bio-Thera Solutions, Ltd. ·
- Official issuer and R&D disclosure · Bio-Thera Solutions, Ltd. ↗Bio-Thera Solutions, Ltd. ·
Inclusion is not endorsement or partner qualification. Assess company claims, clinical evidence, and project-specific capabilities separately.